Bristol-Myers Squibb Company 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:05 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 4.300% | 0 (Unchanged) | Filing |
| 2023-12-04 4:13 pm Purchase | 2023-11-27 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 6.400% | 5,075,304 (New Position) | Filing |